Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Trepo

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|February 8, 2014
Occult HBV infection in Morocco: from chronic hepatitis to hepatocellular carcinomaBouchra Kitab, Sayeh Ezzikouri, Rhimo Alaoui, et al.
Gastroenterologie Clinique Et Biologique|March 10, 2007
Satisfaction of patients treated for chronic hepatitis C with the peginterferon alfa-2b pen device: the VISA observational studyJean-François Cadranel, Jean-Louis Boujenah, Marc Bourlière, et al.
Journal of Medical Virology|June 29, 2004
Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assaysDamien Jeantet, Isabelle Chemin, Bernard Mandrand, et al.
European Journal of Gastroenterology & Hepatology|March 13, 2009
Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 16 casesJean-François Dufour, Pierre Pradat, Marc Ruivard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2007
Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversionPatrick Miailhes, Mary-Anne Trabaud, Pierre Pradat, et al.
The Journal of General Virology|April 19, 2008
DNA vaccination in combination or not with lamivudine treatment breaks humoral immune tolerance and enhances cccDNA clearance in the duck model of chronic hepatitis B virus infectionAlexandre Thermet, Thierry Buronfosse, Bettina Werle-Lapostolle, et al.
Gastroenterology|May 2, 2002
Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis CThierry Poynard, John McHutchison, Michael Manns, et al.
The Journal of Infectious Diseases|April 30, 2004
Quantification and functional analysis of plasmacytoid dendritic cells in patients with chronic hepatitis C virus infectionNadege Goutagny, Claude Vieux, Evelyne Decullier, et al.
Journal of Medical Virology|January 30, 2019
Non-F HBV/HDV-3 coinfection is associated with severe liver disease in Western Brazilian AmazonEdinete Melo Da Silva, Alan Kay, Cirley Lobato, et al.
Cancer Causes & Control : CCC|July 9, 2003
Smoking and non-Hodgkin's lymphoma: a case-control study in the Rhône-Alpes region of FranceHervé Besson, Philippe Renaudier, Ray M Merrill, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Liver International : Official Journal of the International Association for the Study of the Liver|February 8, 2014
Occult HBV infection in Morocco: from chronic hepatitis to hepatocellular carcinomaBouchra Kitab, Sayeh Ezzikouri, Rhimo Alaoui, et al.
Gastroenterologie Clinique Et Biologique|March 10, 2007
Satisfaction of patients treated for chronic hepatitis C with the peginterferon alfa-2b pen device: the VISA observational studyJean-François Cadranel, Jean-Louis Boujenah, Marc Bourlière, et al.
Journal of Medical Virology|June 29, 2004
Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assaysDamien Jeantet, Isabelle Chemin, Bernard Mandrand, et al.
European Journal of Gastroenterology & Hepatology|March 13, 2009
Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 16 casesJean-François Dufour, Pierre Pradat, Marc Ruivard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2007
Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversionPatrick Miailhes, Mary-Anne Trabaud, Pierre Pradat, et al.
The Journal of General Virology|April 19, 2008
DNA vaccination in combination or not with lamivudine treatment breaks humoral immune tolerance and enhances cccDNA clearance in the duck model of chronic hepatitis B virus infectionAlexandre Thermet, Thierry Buronfosse, Bettina Werle-Lapostolle, et al.
Gastroenterology|May 2, 2002
Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis CThierry Poynard, John McHutchison, Michael Manns, et al.
The Journal of Infectious Diseases|April 30, 2004
Quantification and functional analysis of plasmacytoid dendritic cells in patients with chronic hepatitis C virus infectionNadege Goutagny, Claude Vieux, Evelyne Decullier, et al.
Journal of Medical Virology|January 30, 2019
Non-F HBV/HDV-3 coinfection is associated with severe liver disease in Western Brazilian AmazonEdinete Melo Da Silva, Alan Kay, Cirley Lobato, et al.
Cancer Causes & Control : CCC|July 9, 2003
Smoking and non-Hodgkin's lymphoma: a case-control study in the Rhône-Alpes region of FranceHervé Besson, Philippe Renaudier, Ray M Merrill, et al.
Pageof 7